GBL-310

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGBL-310
Drug Alias NameGBL-310
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 activatorsMitogen-activated protein kinase inhibitorsApoptosis inducers
TargetsMitogen-activated protein kinaseCaspase-3
Therapy Area/IndicationsKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGrannus Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrannus Biosciences
Active IndicationsN/A
Inactive IndicationsKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksN/A